[1]Mccourt C, Dolan O, Gormley G. Malignant melanoma: a pictorial review[J]. Ulster Med J,2014, 83(2): 103-110.
[2]de Vries E, Houterman S, Janssen-Heijnen ML, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands[J]. Ann Oncol, 2007, 18(6): 1110-1116.
[3]Hu N, Wang C, Clifford RJ, et al. Integrative genomics analysis of genes with biallelic loss and its relation to the expression of mRNA and micro-RNA in esophageal squamous cell carcinoma[J]. BMC Genomics, 2015, 16(l):732.
[4]Streicher KL, Zhu W, Lehmann KP, et al. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth[J]. Oncogene, 2011, 31(12): 1558-1570.
[5]Mazar J, DeBlasio D, Govindarajan SS, et al. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans[J]. FEBS Lett, 2011, 585(15): 2467-2476. [6]Nguyen T, Kuo C, Nicholl MB, et al. Downregulation of microRNA-29c is associated with hypermethylation of tumorrelated genes and disease outcome in cutaneous reelanoma[J]. Epigenetics, 20ll, 6(3): 388-394.
[7]Segura MF, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing F0X03 and microphthalmia-associated transcription factor[J]. Proc Natl Acad Sci USA, 2009, 106(6):1814-1819.
[8]Zhang W, Qian P, Zhang X, et al. Autocrine/paracrine human growth hormone stimulated miRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancer [J]. J Biol Chem, 2015, 290(22):13812-13829.
[9]Boniol M, Autier P, Boyle P, et al. Cutaneous melanoma attributable to sunbed use:systematic review and meta-analysis[J]. BMJ, 2012, 345:4757-4763.
[10]Li P, Sheng C, Huang L, et al. MiR-183/-96/-182 cluster is upregulated in most breast cancers and increases cell proliferation and migration[J]. Breast Cancer Res, 2014, 16(6): 473.
[11]Kong WQ, Bai R, Liu T, et al. MicroRNA-182 targets cAMPresponsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma[J]. FEBS J, 2012, 279(7):1252-1260.
[12]Wang S, Yang MH, Wang XY, et al. Increased expression of miRNA-182 in colorectal carcinoma: an independent and tissuespecific prognostic factor[J]. Int J Clin Exp Pathol, 2014, 7(6):3498-3503.
[13]Xu X, Wu J, Li S, et al. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway[J]. Mol Cancer, 2014, 13(3):109.
[14]Jin ZK, Li JJ, Du DL, et al. Down-regulation ofmiR-182 and miR-183 acts as potential predictor biomarkers in progression,metastasis,and poor prognosis of non-small cell lung cancer[J]. Int J Clin Exp Pathol,2016,9(3):3430-3435.
[15]Wang TH,Yeh CT,Ho JY, et al. OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma[J]. Mol Carcinog,2016,55(4):366-375.
[16 Benjamin S, Wu DY, Chen Z,et al.Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence[J]. Nucleic Acids Res,2016,44(9):4105-4122.
[17]Pigazzi M, Ricotti E, German Q, et al. cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression[J]. Haematologica, 2007,92(10): 1435-1437.
[18]Stephen P, Moore G, Joshua K,et al.Transcription factors and DNA repair enzymes compete for damaged promoter sites[J]. J Biol Chem,2016, 291(11):5452-5460.
|